Sanofi - revenue by segment 2014-2022

In 2022, the French pharmaceutical and healthcare company by the name of Sanofi generated approximately 31 billion U.S. dollars through its pharmaceuticals segment. Sanofi’s relatively new consumer healthcare segment earned the company about 5.1 billion U.S. dollars in that year.

Sanofi’s top products

Sanofi develops various pharmaceutical products, including Aubagio, Lovenox, and Dupixent. One of the company’s top products based on revenue is also Lantus. In 2022, this long-acting insulin used to treat diabetes, generated some 2.3 billion U.S. dollars. Aubagio earned the company roughly two billion U.S. dollars within the same year.

Top U.S. drugs

Based on sales numbers over the last years, Humira is by far the top prescription drug in the United States. The drug generates over 20 billion U.S. dollars in the United States per year. Among the country’s most prescribed medicines, however, are atorvastatin, lisinopril, and levothyroxine.